Synairgen (SNG) RNS Announcements

Add to Alert list
Date Time Source Announcement
09 Jun 2014 01:00 PM
RNS
Result of AGM
16 May 2014 07:00 AM
RNS
Notice of AGM
09 May 2014 02:57 PM
RNS
Notice of Report and Accounts
20 Mar 2014 07:00 AM
RNS
Preliminary Results
11 Mar 2014 05:05 PM
RNS
Holding(s) in Company
06 Mar 2014 12:58 PM
RNS
Holding(s) in Company
05 Mar 2014 07:00 AM
RNS
Licensing Update, Placing & Notice of results
06 Dec 2013 03:45 PM
PRN
Net Asset Value(s)
14 Oct 2013 09:05 AM
RNS
Exercise of Options
12 Aug 2013 07:00 AM
RNS
Half Yearly Report
18 Jul 2013 07:00 AM
RNS
Positive anti-inflammatory and anti-viral data
03 Jul 2013 03:05 PM
RNS
Holding(s) in Company
10 Jun 2013 01:45 PM
RNS
Result of AGM
21 May 2013 11:10 AM
RNS
Holding(s) in Company
09 May 2013 12:45 PM
RNS
Notice of AGM
09 Apr 2013 04:26 PM
RNS
Posting of Annual Report
12 Mar 2013 07:00 AM
RNS
Grant of Options
13 Feb 2013 07:00 AM
RNS
Preliminary Results
05 Dec 2012 07:00 AM
RNS
Trading Update
30 Oct 2012 01:44 PM
RNS
Director/PDMR Shareholding
25 Sep 2012 07:00 AM
RNS
Exercise of Options
31 Aug 2012 07:00 AM
RNS
Synairgen presents proof of concept study
10 Aug 2012 07:00 AM
RNS
Half Yearly Report
18 Jul 2012 07:00 AM
RNS
Placing
25 Jun 2012 01:30 PM
RNS
Result of AGM
22 May 2012 07:30 AM
RNS
Professor Stephen Holgate given prestigious Award
01 May 2012 12:55 PM
RNS
Holding(s) in Company
19 Apr 2012 07:00 AM
RNS
Positive Phase II asthma data
02 Mar 2012 07:00 AM
RNS
Notice of Report and Accounts
01 Feb 2012 07:00 AM
RNS
Preliminary results
30 Jan 2012 07:00 AM
RNS
Notice of Results
12 Dec 2011 07:00 AM
RNS
Director's dealing
08 Dec 2011 07:00 AM
RNS
End of Recruitment in Phase II Asthma Trial
25 Nov 2011 07:00 AM
RNS
Positive Viral Pneumonia Study Results
10 Nov 2011 12:40 PM
RNS
Result of AGM
18 Oct 2011 01:50 PM
RNS
Notice of AGM and posting of Annual Reports
22 Sep 2011 03:10 PM
RNS
Grant of options
13 Sep 2011 07:00 AM
RNS
Preliminary Results
09 Sep 2011 07:00 AM
RNS
Change of Adviser
18 Jul 2011 07:00 AM
RNS
Japanese Patent to be Granted
28 Jun 2011 07:00 AM
RNS
Phase II asthma study - Interim Review and update
15 Jun 2011 03:56 PM
RNS
Holding(s) in Company
13 Jun 2011 11:54 AM
RNS
Result of General Meeting
27 May 2011 01:00 PM
RNS
Fundraising
04 May 2011 07:00 AM
RNS
Antiviral activity against Bird Flu
02 Feb 2011 11:31 AM
RNS
Holding(s) in Company
01 Feb 2011 07:00 AM
RNS
Half Yearly Report
03 Nov 2010 01:35 PM
RNS
Result of AGM
19 Oct 2010 07:00 AM
RNS
US Patent
08 Oct 2010 09:00 AM
RNS
Notice of AGM and Posting of

Synairgen is a University spin-off and public limited company working in drug discovery and biotechnology. It was founded in 2003 by University of Southampton professors Stephen Holgate, Donna E. Davies and Ratko Djukanovic.

Synairgen is a specialist respiratory biotech company whose primary focus is developing our investigative inhaled interferon beta candidate (SNG001) for severe viral lung infections.

Synairgen share price launched at 155p in 2004.

UK 100

Latest directors dealings